Effects of DPP-4 Inhibitors on Cardiovascular System in Type 2 Diabetes

被引：0
|
作者：
Ohno, Yasuhiro [1 ]
Tanaka, Yoichi [1 ]
Fujimoto, Mika [1 ]
Maruyama, Yasunori [1 ]
机构：
[1] Kinki Univ, Sakai Hosp, Fac Med, Sakai, Osaka, Japan
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
MON-1052
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cardiovascular effects of the DPP-4 inhibitors
    Jose, Tessey
    Inzucchi, Silvio E.
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (02): : 109 - 116
  • [2] DPP-4 inhibitors in the treatment of type 2 diabetes
    Duez, Helene
    Cariou, Bertrand
    Staels, Bart
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (07) : 823 - 832
  • [3] An update on DPP-4 inhibitors in the management of type 2 diabetes
    Cahn, Avivit
    Cernea, Simona
    Raz, Itamar
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (04) : 409 - 419
  • [4] A Clinical Overview of DPP-4 Inhibitors for Type 2 Diabetes
    Jeon, Michelle
    Took, Roxane L.
    Peters, Golden L.
    US PHARMACIST, 2018, 43 (10) : 49 - 56
  • [5] The Effects of DPP-4 Inhibitors on Plasma Catecholamines and Their Metabolites in Patients with Type 2 Diabetes
    Park, Ie Byung
    Lee, Daeho
    Lee, Kiyoung
    DIABETES, 2019, 68
  • [6] DPP-4 inhibitors and their potential role in the management of type 2 diabetes
    Barnett, A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (11) : 1454 - 1470
  • [7] Influence of metformin on cardiovascular effects of DPP-4 inhibitors
    Jecht M.
    Der Diabetologe, 2018, 14 (1): : 48 - 50
  • [8] Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
    Gallwitz, Baptist
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 1 - 9
  • [9] Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes
    Sutton, Jon M.
    Clark, David E.
    Dunsdon, Stephen J.
    Fenton, Garry
    Fillmore, Amanda
    Harris, Neil V.
    Higgs, Chris
    Hurley, Chris A.
    Krintel, Sussie L.
    MacKenzie, Robert E.
    Duttaroy, Alokesh
    Gangl, Eric
    Maniara, Wiesia
    Sedrani, Richard
    Namoto, Kenji
    Ostermann, Nils
    Gerhartz, Bernd
    Sirockin, Finton
    Trappe, Joerg
    Hassiepen, Ulrich
    Baeschlin, Daniel K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (03) : 1464 - 1468
  • [10] Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
    Ahren, Bo
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 31 - 41
12345